Aralez Pharma (ARLZ) Reports Q4 Loss of $0.48/Share

Aralez Pharma (NASDAQ: ARLZ) reported Q4 EPS of ($0.48), versus ($0.40) reported last year. Revenue for the quarter came in at $20 million, versus $6 million reported last year.

GUIDANCE:

Aralez Pharma sees FY2017 revenue of $80-100 million.

For earnings history and earnings-related data on Aralez Pharma (ARLZ) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance